Advancements in Sickle Cell Disease (SCD) Treatment: A Review of Novel Pharmacotherapies and Their Impact on Patient Outcomes

Sickle cell disease (SCD) is a genetic hereditary blood disease that disrupts normal beta-globin production. Patients with SCD experience a broad range of symptoms ranging from anemia, pain crises, and jaundice to acute coronary syndrome and stroke. SCD has been treated with hydroxyurea since 1998. ...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Salman J, Zaidi, Syed Asjad Tauheed, Murtaza, Syeda Fatima, Asif, Muhammad, Kumar, Vinod
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472971/
https://www.ncbi.nlm.nih.gov/pubmed/37664319
http://dx.doi.org/10.7759/cureus.42847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472971/
https://www.ncbi.nlm.nih.gov/pubmed/37664319
http://dx.doi.org/10.7759/cureus.42847

Ejemplares similares